FIELD: medicine.
SUBSTANCE: invention refers to ophthalmology, and can be used in children underwent surgery of congenital cataract to predict potential opacities of posterior capsule of lens (OPCL). The method in ensured by evaluating the level of pro- and antiinflammatory cytokines and calculating an intraocular immunological index by formula. If the III is under 1.1, preserved postoperative transparency of capsule of lens is predicted, the III within 1.2 to 1.5 shows most probable late fibrosis of capsule of lens within 3-4 months after operation.
EFFECT: possibility to predict high risk of development of postinflammatory fibrosis of capsule of lens within first 3 months after operation, in case when the III exceeds 1,5.
1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING RISK OF DEVELOPMENT AND PROGRESSION RATE OF LENS CAPSULE FIBROSIS FOLLOWING CONGENITAL CATARACT REMOVAL IN INFANTS | 2011 |
|
RU2453846C1 |
METHOD FOR PREDICTION OF DEVELOPING OR PROGRESSING PROLIFERATIVE SYNDROME IN ENDOGENOUS UVEITIS IN CHILDREN | 2015 |
|
RU2584246C1 |
WAY OF FORECASTING OF ADVANCE OF PROLIFERATIVE COMPLICATIONS AT PERIPHERIC UVEITES AT CHILDREN | 2008 |
|
RU2362172C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING SECONDARY SPECIFIC CATARACT | 2012 |
|
RU2512744C1 |
METHOD FOR TREATING SEMI-RESOLVED INBORN CATARACT IN CHILDREN AT PERSISTENT HYPERPLASTIC PRIMARY VITREOUS SYNDROME | 2004 |
|
RU2282424C1 |
METHOD OF TREATING SECONDARY CATARACT ON EYES WITH PSEUDOPHAKIA AFTER EXTRACTION OF CONGENITAL CATARACT IN CHILDREN | 2018 |
|
RU2705411C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF POSTVACCINAL PROCESS IN CHILDREN WITH AFFECTED CENTRAL NERVOUS SYSTEM | 2014 |
|
RU2580889C1 |
METHOD FOR EARLY PREDICTION OF RISK OF DEVELOPING PERIPHERAL VITREOCHORIORETINAL DYSTROPHIES ON PAIRED EYE AFTER REGMATOGENOUS RETINAL DETACHMENT SURGERIES | 2014 |
|
RU2540505C1 |
METHOD FOR PREDICTING CONGENITAL CATARACT DEVELOPMENT RISK | 1999 |
|
RU2152031C1 |
METHOD FOR PREDICTION OF ORGAN-SPECIFIC SELF-IMMUNISATION IN INFLAMMATORY EYE DISORDERS | 2014 |
|
RU2564929C1 |
Authors
Dates
2010-02-20—Published
2008-12-02—Filed